SMO ClinPlus CO.,LTD. (SHE:301257)

China flag China · Delayed Price · Currency is CNY
27.99
+0.11 (0.39%)
At close: May 16, 2025, 2:57 PM CST
-17.56%
Market Cap 2.23B
Revenue (ttm) 795.66M
Net Income (ttm) 91.12M
Shares Out 79.50M
EPS (ttm) 1.08
PE Ratio 25.96
Forward PE 20.28
Dividend 0.18 (0.64%)
Ex-Dividend Date n/a
Volume 2,184,320
Average Volume 1,915,792
Open 27.77
Previous Close 27.88
Day's Range 27.70 - 28.32
52-Week Range 23.07 - 39.45
Beta 0.90
RSI 45.63
Earnings Date Apr 29, 2025

About SMO ClinPlus CO.,LTD.

SMO ClinPlus CO.,LTD. provides site management services in research development in pharmaceuticals, medical devices, and health-related products in China. The company’s SMO services include preliminary model establishment, preliminary plan preparation, initiation of clinical trial sites, on-site implementation, and project management services. SMO ClinPlus CO.,LTD. was founded in 2009 and is based in Shanghai, China. [Read more]

Sector Healthcare
Founded 2009
Employees 4,186
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301257
Full Company Profile

Financial Performance

In 2024, SMO ClinPlus CO.,LTD.'s revenue was 803.73 million, an increase of 5.75% compared to the previous year's 760.04 million. Earnings were 106.43 million, a decrease of -21.01%.

Financial Statements

News

There is no news available yet.